Osteoporosis International

, Volume 19, Issue 4, pp 581–587 | Cite as

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

  • A. Papaioannou
  • C. C. Kennedy
  • G. Ioannidis
  • Y. Gao
  • A. M. Sawka
  • D. Goltzman
  • A. Tenenhouse
  • L. Pickard
  • W. P. Olszynski
  • K. S. Davison
  • S. Kaiser
  • R. G. Josse
  • N. Kreiger
  • D. A. Hanley
  • J. C. Prior
  • J. P. Brown
  • T. Anastassiades
  • J. D. Adachi
  • CaMos Research Group
Original Article

Abstract

Summary

We examined osteoporosis diagnosis/treatment in 2,187 community dwelling men age 50+. After five years in the study, 90% of men with fragility fractures remained undiagnosed and untreated for osteoporosis. The need to treat fragility fractures is well established in guidelines, and these numbers represent an important care gap.

Introduction

Whether physicians in the community are recognizing and appropriately treating osteoporosis and fragility fractures in men remains unknown. We examined the rate of diagnosis and treatment in community dwelling men participating in the Canadian Multicentre Osteoporosis Study (CaMos).

Methods

Between February 1996 and September 2002, 2,187 participants were recruited from nine sites across Canada and prospectively followed. Information on osteoporosis diagnosis, fractures, medications were collected annually by a detailed questionnaire. DXA examination of lumbar spine (L1-4) and hip were conducted at baseline and year five.

Results

Diagnosis and treatment in men with clinical fragility fractures was low: at baseline and year five only 2.3% and 10.3% of men with a clinical fracture reported an osteoporosis diagnosis, respectively. At year five, 90% of men with a clinical fragility fracture were untreated. Hip fractures were the most commonly treated (37.5% by year five). A diagnosis of osteoporosis resulted in greater treatment: 67% of participants with diagnosed osteoporosis were treated with a bisphosphonate and 87% were taking calcium and/or vitamin D (year five).

Conclusions

In this population-based study, both a diagnostic and therapeutic gap existed between knowledge and practice related to fragility fractures and osteoporosis in men aged ≥50 years.

Keywords

Bisphosphonate Care gap Diagnosis Fractures Males Osteoporosis 

References

  1. 1.
    National Osteoporosis Foundation (2002) America’s bone health: the state of osteoporosis and bone health. National Osteoporosis Foundation, Washington, DC. USAGoogle Scholar
  2. 2.
    Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289PubMedCrossRefGoogle Scholar
  3. 3.
    Pluijm SM, Tromp AM, Smit JH et al (2000) Consequences of vertebral deformities in older men and women. J Bone Miner Res 15:1564–1572PubMedCrossRefGoogle Scholar
  4. 4.
    Burger H, Van Daele PL, Grashuis K et al (1997) Vertebral deformities and functional impairment in men and women. J Bone Miner Res 12:152–157PubMedCrossRefGoogle Scholar
  5. 5.
    Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11:680–687PubMedCrossRefGoogle Scholar
  6. 6.
    Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674PubMedCrossRefGoogle Scholar
  7. 7.
    Melton LJ 3rd, Chrischilles EA, Cooper C et al (2005) How many women have osteoporosis? JBMR Anniversary Classic. JBMR, Volume 7, Number 9, 1992. J Bone Miner Res 20:886–892PubMedCrossRefGoogle Scholar
  8. 8.
    Forsen L, Sogaard AJ, Meyer HE et al (1999) Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int 10:73–78PubMedCrossRefGoogle Scholar
  9. 9.
    Jiang HX, Majumdar SR, Dick DA et al (2005) Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 20:494–500PubMedCrossRefGoogle Scholar
  10. 10.
    Hawkes WG, Wehren L, Orwig D et al (2006) Gender differences in functioning after hip fracture. J Gerontol A Biol Sci Med Sci 61:495–499PubMedGoogle Scholar
  11. 11.
    Osnes EK, Lofthus CM, Meyer HE et al (2004) Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int 15:567–574PubMedCrossRefGoogle Scholar
  12. 12.
    Marottoli RA, Berkman LF, Leo-Summers L et al (1994) Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established populations for epidemiologic studies of the elderly. Am J Public Health 84:1807–1812PubMedGoogle Scholar
  13. 13.
    Papaioannou A, Wiktorowicz M, Adachi JD et al (2000) Mortality, independence in living, and re-fracture, one year following hip fractures in Canadians. J Obstet Gynaecol Can 22:591–597Google Scholar
  14. 14.
    Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRefGoogle Scholar
  15. 15.
    Papaioannou A, Giangregorio L, Kvern B et al (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11PubMedCrossRefGoogle Scholar
  16. 16.
    Giangregorio L, Papaioannou A, Cranney A et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305PubMedCrossRefGoogle Scholar
  17. 17.
    National Osteoporosis Foundation [homepage on the Internet] Washington, DC. USA. National Osteoporosis Foundation, c2003 [cited June 2006]. Physician’s Guide to Prevention and Treatment of Osteoporosis; [about 1 screen]. Available from: http://noforg/physguide/
  18. 18.
    (1996) Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. CMAJ 155:1113–1133Google Scholar
  19. 19.
    Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1–S34PubMedGoogle Scholar
  20. 20.
    Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRefGoogle Scholar
  21. 21.
    Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRefGoogle Scholar
  22. 22.
    Phillipov G, Phillips PJ, Leach G et al (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556PubMedCrossRefGoogle Scholar
  23. 23.
    Juby AG, Davis P (2001) A prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjects. Osteoporos Int 12:617–622PubMedCrossRefGoogle Scholar
  24. 24.
    Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163:819–822PubMedGoogle Scholar
  25. 25.
    Kreiger N, Tenenhouse A, Joseph L et al (2002) The Canadian Multicenter Osteoporosis Study (CaMos): background, rationale, methods. Can J Aging 18:376–387Google Scholar
  26. 26.
    Genant HK, Grampp S, Gluer CC et al (1994) Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503–1514PubMedCrossRefGoogle Scholar
  27. 27.
    Tenenhouse A, Joseph L, Kreiger N et al (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904PubMedCrossRefGoogle Scholar
  28. 28.
    Sawka AM, Thabane L, Papaioannou A et al (2005) A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 8:7–13PubMedCrossRefGoogle Scholar
  29. 29.
    Ringe JD, Faber H, Farahmand P et al (2006) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26:427–431PubMedCrossRefGoogle Scholar
  30. 30.
    Sawka AM, Papaioannou A, Adachi JD et al (2005) Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 6:39PubMedCrossRefGoogle Scholar
  31. 31.
    Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRefGoogle Scholar
  32. 32.
    Simonelli C, Killeen K, Mehle S et al (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77:334–338PubMedGoogle Scholar
  33. 33.
    Jaglal SB, McIsaac WJ, Hawker G et al (2003) Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 14:672–676PubMedCrossRefGoogle Scholar
  34. 34.
    Papaioannou A, Coker E, Kennedy CK et al (2004) A multi-faceted post fracture care model: the fracture? Think osteoporosis! Program. J Bone Miner Res 19:S318Google Scholar
  35. 35.
    Bogoch ER, Elliot-Gibson V, Beaton DE et al (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88:25–34PubMedCrossRefGoogle Scholar
  36. 36.
    Harrington JT, Barash HL, Day S et al (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53:198–204PubMedCrossRefGoogle Scholar
  37. 37.
    Kmetic A, Joseph L, Berger C et al (2002) Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis. Epidemiology 13:437–444PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  • A. Papaioannou
    • 1
  • C. C. Kennedy
    • 1
  • G. Ioannidis
    • 1
  • Y. Gao
    • 2
  • A. M. Sawka
    • 3
  • D. Goltzman
    • 4
  • A. Tenenhouse
    • 4
  • L. Pickard
    • 1
  • W. P. Olszynski
    • 5
  • K. S. Davison
    • 6
  • S. Kaiser
    • 7
  • R. G. Josse
    • 3
  • N. Kreiger
    • 3
  • D. A. Hanley
    • 8
  • J. C. Prior
    • 9
  • J. P. Brown
    • 6
  • T. Anastassiades
    • 10
  • J. D. Adachi
    • 1
  • CaMos Research Group
  1. 1.Division of Geriatric MedicineMcMaster UniversityHamiltonCanada
  2. 2.CaMos Analysis CentreMcGill UniversityMontrealCanada
  3. 3.University of TorontoTorontoCanada
  4. 4.McGill UniversityMontrealCanada
  5. 5.University of SaskatchewanSaskatoonCanada
  6. 6.Laval UniversitySte-FoyCanada
  7. 7.Dalhousie UniversityHalifaxCanada
  8. 8.University of CalgaryCalgaryCanada
  9. 9.University of British ColumbiaVancouverCanada
  10. 10.Queen’s UniversityKingstonCanada

Personalised recommendations